NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.17% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.10% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.03% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.87% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.78% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.72% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.68% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.67% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.64% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.63% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.62% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.56% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.51% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.49% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.44% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.42% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.40% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.40% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.33% |